Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Smith & Nephew Plc
  6. Company
    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Smith & Nephew Plc
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Number of employees : 17 914 people.
Sales per Business
20192020Delta
Orthopedics1 741.7443.2%1 494.9142% -14.17%
Sports Medicine & Ear, Nose and Throat1 204.0129.9%1 039.4929.2% -13.66%
Advanced Wound Management1 081.7326.9%1 021.5628.7% -5.56%
GBP in Million
Sales per region
20192020Delta
United States1 999.6349.6%1 823.9951.3% -8.78%
Established Markets1 112.3027.6%1 001.2828.2% -9.98%
Emerging Markets486.7812.1%353.269.9% -27.43%
China263.386.5%247.987% -5.85%
United Kingdom165.394.1%129.453.6% -21.73%
GBP in Million
Managers
Name Title Age Since
Roland Diggelmann Chief Executive Officer & Non-Executive Director 53 2019
Anne-Francoise Nesmes Chief Financial Officer & Executive Director 49 2020
Vasant Padmanabhan President-Research & Development 53 2016
Catheryn O'Rourke Chief Legal & Compliance Officer 48 2018
Erik Nils Engstrom Independent Non-Executive Director 57 2015
Robin Freestone Senior Independent Non-Executive Director 61 2019
Angela Susan Risley Independent Non-Executive Director 62 2017
Marc E. Owen Independent Non-Executive Director 61 2017
Charles Richard Kenneth Medlock Independent Non-Executive Director 60 2020
Robert White Independent Non-Executive Director 57 2020
Members of the board
Name Title Age Since
Roberto Quarta Chairman 72 2014
Erik Nils Engstrom Independent Non-Executive Director 57 2015
Robin Freestone Senior Independent Non-Executive Director 61 2019
Angela Susan Risley Independent Non-Executive Director 62 2017
Marc E. Owen Independent Non-Executive Director 61 2017
Roland Diggelmann Chief Executive Officer & Non-Executive Director 53 2019
Charles Richard Kenneth Medlock Independent Non-Executive Director 60 2020
Robert White Independent Non-Executive Director 57 2020
Anne-Francoise Nesmes Chief Financial Officer & Executive Director 49 2020
Katarzyna Mazur-Hofsaess, Dr. Non-Executive Director 58 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 885,195,917 877,022,454 99.1% 5,906,142 0.7% 99.1%
Shareholders
NameEquities%
Wellington Management Co. LLP 42,665,590 4.82%
Thornburg Investment Management, Inc. 28,282,441 3.20%
WCM Investment Management LLC 27,168,133 3.07%
BlackRock Fund Advisors 24,767,742 2.80%
The Vanguard Group, Inc. 20,594,901 2.33%
Norges Bank Investment Management 19,491,000 2.20%
Walter Scott & Partners Ltd. 19,103,273 2.16%
Rathbone Investment Management Ltd. 16,846,000 1.90%
Legal & General Investment Management Ltd. 10,312,305 1.17%
BlackRock Advisors (UK) Ltd. 9,961,000 1.13%
Holdings
NameEquities%Valuation
BIOVENTUS, INC. 15,786,737 100.0% 229,065,554 USD
BIOVENTUS INC. (BVS) 6,229,991 15.2% 90,397,169 USD
BIOVENTUS, INC. 16,534,814
Markets and indexes
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, STOXX Europe 600, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  SN/:LN
- Reuters Code :  SN.L
- Datastream Code :  
Company contact information
Smith & Nephew Plc
Building 5 Croxley Park
WD18 8YE Watford, Hertfordshire

Phone : +44 20 7401 7646
Fax : +44 20 7960 2356
web site : http://www.smith-nephew.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Smith & Nephew Plc